
Publication|Articles|October 10, 2025
- October 2025
- Volume 91
- Issue 10
FDA Approvals for September 2025
Author(s)PT Staff
Key Takeaways
- Recent FDA approvals highlight advancements in oncology, focusing on therapies targeting specific genetic mutations for personalized treatment.
- Expedited review processes by the FDA have enabled quicker access to innovative cancer treatments, improving patient outcomes.
Explore recent FDA-approved drugs from September 2025.
Advertisement
FDA Approvals
Articles in this issue
8 months ago
OTC Case Studies: Dry EyeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Medicare Is Finally Covering GLP-1s for Weight Loss: What the Bridge Program Means for Your Practice
2
Updated 2025-2026 COVID-19 Vaccine Nearly Halved ED Visits, Hospitalizations in CDC-Funded Study
3
The Biosimilar Conversation Nobody Is Having at the Pharmacy Counter: Why Adoption Is Still Struggling and What We Can Do About It
4
FDA Narrows Compounding Rules for GLP-1s: How Pharmacists Should Respond
5



















































































































